NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, ...
Progresses Novel Targeted Anti-Cancer Therapies in Clinical Development Initiates Phase Ib/IIa Clinical Trial of ...
- Data from the Company’s Actimab-A program to be presented in the Clinical Experiences ...
